You know what they say: when life gives you lemons…you engage in risk-taking behavior. At least that’s what a recent study concluded by measuring participants’ willingness to take risks after being exposed to the five main taste groups. Dr. Matt Birnholz reports.
Do Sour Tastes Make Us Better Risk Takers?
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
You know what they say: when life gives you lemons…you engage in risk-taking behavior. At least that’s what a recent study concluded by measuring participants’ willingness to take risks after being exposed to the five main taste groups. Dr. Matt Birnholz reports.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
FCS and SHTG: Are We Meeting the Need?
0.25 credits
<p>FCS and SHTG: Are We Meeting the Need?</p>
VacciNation
Targeting Prevalent Flu Strains Through Strategic Vaccine Selection
<p>Targeting Prevalent Flu Strains Through Strategic Vaccine Selection</p>
CME/CE
Updates From the 7th World Symposium Task Force
1.00 credits
<p><span data-contrast="auto" xml:lang="EN-US">Updates From the 7th World Symposium Task Force</span><span data-ccp-props='{"201341983":0,"335559738":210,"335559739":210,"335559740":240}'> </span></p>
MinuteCE®
Selecting the Optimal ICI Partner for First-Line Treatment of Unresectable HCC: CTLA-4 vs VEGF Inhibitors
1.00 credits
<p>Selecting the Optimal ICI Partner for First-Line Treatment of Unresectable HCC: CTLA-4 vs VEGF<strong> </strong>Inhibitors</p>
MinuteCE®
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
1.00 credits
<p>Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D</p>
MinuteCE®
Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy
0.75 credits
<p>Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy </p>
CME/CE
Antibody-Drug Conjugates in Bladder Cancer: Guideline Updates and Adverse Event Management
0.50 credits
<p>Antibody-Drug Conjugates in Bladder Cancer: Guideline Updates and Adverse Event Management</p>
MinuteCE®
Reviewing the Latest Bladder Cancer Practice Guidelines
0.50 credits
<p>Reviewing the Latest Bladder Cancer Practice Guidelines</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?